Contineum Therapeutics, Inc.
CTNM
$4.95
$0.337.14%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 204.76M | 213.91M | 218.65M | 117.91M | 125.19M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.63M | 1.23M | 1.67M | 1.80M | 2.52M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 206.39M | 215.14M | 220.32M | 119.71M | 127.71M |
|
|
|||||
| Total Current Assets | 206.39M | 215.14M | 220.32M | 119.71M | 127.71M |
| Net Property, Plant & Equipment | 6.46M | 888.00K | 1.03M | 1.23M | 1.40M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 3.00K | 3.00K | 3.00K | 2.62M | 1.28M |
| Total Assets | 212.85M | 216.03M | 221.36M | 123.56M | 130.39M |
|
|
|||||
| Total Accounts Payable | 1.81M | 1.40M | 734.00K | 570.00K | 635.00K |
| Total Accrued Expenses | 6.71M | 3.80M | 2.52M | 5.19M | 4.39M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.45M | 611.00K | 484.00K | 474.00K | 464.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 9.97M | 5.81M | 3.74M | 6.23M | 5.48M |
|
|
|||||
| Total Current Liabilities | 9.97M | 5.81M | 3.74M | 6.23M | 5.48M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 4.81M | -- | 113.00K | 111.00K | 108.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | 228.00K | 110.00K |
| Total Liabilities | 14.78M | 5.81M | 3.85M | 6.57M | 5.70M |
|
|
|||||
| Common Stock & APIC | 315.40M | 312.50M | 310.20M | 7.99M | 7.10M |
| Retained Earnings | -117.40M | -102.84M | -92.57M | -83.56M | -75.14M |
| Treasury Stock & Other | 71.00K | 561.00K | -127.00K | -58.00K | 108.00K |
| Total Common Equity | 198.07M | 210.23M | 217.50M | -75.63M | -67.94M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | 192.62M | 192.62M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | 192.62M | 192.62M |
|
|
|||||
| Total Common Equity | 198.07M | 210.23M | 217.50M | -75.63M | -67.94M |
| Total Preferred Equity | -- | -- | -- | 192.62M | 192.62M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 198.07M | 210.23M | 217.50M | 116.99M | 124.68M |
|
|
|||||